BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24724069)

  • 1. A case of oxaliplatin-induced immune-mediated thrombocytopenia.
    Suh SE; Jang MJ; Chong SY; Aster RH; Curtis BR; Oh D
    Blood Res; 2014 Mar; 49(1):61-4. PubMed ID: 24724069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.
    Curtis SA; Curtis BR; Lee AI; Hendrickson JE; Lacy J; Podoltsev NA
    Hematology; 2018 Aug; 23(7):429-432. PubMed ID: 29281948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?
    James E; Podoltsev N; Salehi E; Curtis BR; Saif MW
    Clin Colorectal Cancer; 2009 Oct; 8(4):220-4. PubMed ID: 19822513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
    Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
    Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy.
    Tam EL; Draksharam PL; Park JA; Sidhu GS
    Case Rep Oncol Med; 2019; 2019():4314797. PubMed ID: 31781443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.
    Bautista MA; Stevens WT; Chen CS; Curtis BR; Aster RH; Hsueh CT
    J Hematol Oncol; 2010 Mar; 3():12. PubMed ID: 20346128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin immune-mediated thrombocytopenia: Is there a role for premedication or desensitization?
    Gal S; Noa M; Ofer M; Naama H; Ben B; Einat SS
    Br J Clin Pharmacol; 2022 Feb; 88(2):842-845. PubMed ID: 34237795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin-induced immune pancytopenia.
    Taleghani BM; Meyer O; Fontana S; Ahrens N; Novak U; Borner MM; Salama A
    Transfusion; 2005 May; 45(5):704-8. PubMed ID: 15847658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin-induced immune mediated thrombocytopenia.
    Beg MS; Komrokji RS; Ahmed K; Safa MM
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia.
    Pan E; Hsieh E; Piatek C
    Case Rep Oncol; 2018; 11(3):880-882. PubMed ID: 30687065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening.
    Vyskocil J; Tucek S; Kiss I; Fedorova L; Nevrlka J; Zdrazilova-Dubska L
    Int Immunopharmacol; 2019 Sep; 74():105728. PubMed ID: 31288153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis.
    Koutras AK; Makatsoris T; Paliogianni F; Kopsida G; Onyenadum A; Gogos CA; Mouzaki A; Kalofonos HP
    Oncology; 2004; 67(2):179-82. PubMed ID: 15539924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of idiosyncratic liver injury after oxaliplatin-induced thrombocytopenia.
    Honda S; Tsujimoto M; Minegaki T; Mori T; Muraoka J; Nishiguchi K
    J Clin Pharm Ther; 2020 Apr; 45(2):373-375. PubMed ID: 31671217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].
    Osumi H; Shinozaki E; Kumekawa Y; Ogura M; Ozaka M; Suenaga M; Matsusaka S; Chin K; Mizunuma N; Yokoyama M
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1557-60. PubMed ID: 24231715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin-induced acute thrombocytopenia.
    Erdem GU; Dogan M; Demirci NS; Zengin N
    J Cancer Res Ther; 2016; 12(2):509-14. PubMed ID: 27461601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
    Curtis BR; Kaliszewski J; Marques MB; Saif MW; Nabelle L; Blank J; McFarland JG; Aster RH
    Am J Hematol; 2006 Mar; 81(3):193-8. PubMed ID: 16493620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irinotecan-induced immune thrombocytopenia.
    Bozec L; Bierling P; Fromont P; Lévi F; Debat P; Cvitkovic E; Misset JL
    Ann Oncol; 1998 Apr; 9(4):453-5. PubMed ID: 9636839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia.
    Yamada S; Yazawa M; Yamamoto M; Koitabashi K; Ichikawa D; Koike J; Shibagaki Y
    CEN Case Rep; 2019 Aug; 8(3):188-193. PubMed ID: 30827015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin-Induced Thrombocytopenia: A Case Report and Review of Pathophysiology of Various Speculative Mechanisms.
    Ghazanfar H; Nawaz I; Ali N
    Cureus; 2020 Aug; 12(8):e9929. PubMed ID: 32968590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case of Drug-Induced Thrombocytopenia Resulting from Sensitivity to Oxaliplatin].
    Masuda T; Nagai K; Sanada K
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2157-9. PubMed ID: 26805296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.